Searched for
HGCO19
Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022The company had submitted the interim Phase-1 clinical trial data to CDSCO, where it tested for safety and immunogenicity.- Pune-based Gennova to use SII's Covishield vaccine as the comparatorTo assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regul...
- The 2-billion Vaccine Question: How realistic are estimates and what's the current status?The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trial...
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...
- Gennova set to kick off trials for India’s first mRNA vaccineCurrently, the two mRNA vaccines that are under use for Covid-19 are by US drug makers Pfizer and Moderna and have shown to have over 90% e...
- AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin"AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. This is a whole-virion inactivated vaccine co-sponsored by Indian Council...
- India's COVID-19 caseload surpasses one crore-mark with 25,152 fresh casesIn a major development, India on Saturday recorded 25,152 new coronavirus cases and 347 deaths, taking the total number of infected people ...
- With over 30,000 new cases, India's COVID-19 tally crosses 9.8 millionWith 30,006 new coronavirus infections and 442 deaths in the past 24 hours, India's overall tally stood at 98,26,775 on Saturday, while the...
- Country's first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBTThe novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology.
- Gennova Biopharmaceuticals granted conditional permission for human clinical trial of its COVID-19 vaccineThe recommendations of the Subject Expert Committee (SEC) on COVID-19, which deliberated upon the proposal submitted by the firm for grant ...
- 3 COVID-19 vaccine candidates under active consideration of drug regulator: Health MinistryOver the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmace...
- The quest for a vaccine: Govt mulls 'Mission COVID Suraksha' with Rs 3,000-cr corpusThe proposed mission will also look to ensure that sufficient volumes are manufactured to meet India's COVID-19 vaccine requirement and to ...
- Human clinical trials of Gennova’s mRNA COVID-19 vaccine to start by the end of this yearPune-based biotechnology company Gennova Biopharmaceuticals will soon start human clinical trials of a Covid-19 vaccine candidate, joining ...
Load More
